Adam Ison
Family · Indianapolis, INNPI 1235827239
Payments from drug & device makers
Across 105 payments — averaging $18.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$390
- Alkermes, Inc.$252
- Johnson & Johnson$250
- Neurocrine Biosciences, Inc.$209
- Otsuka America Pharmaceutical, Inc.$184
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$143
- plus $530 from 13 others
What the payments were for
- Food & beverage$1,91398%
- Education$472%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 20 | $390 |
| Alkermes, Inc. | 15 | $252 |
| Johnson & Johnson | 15 | $250 |
| Neurocrine Biosciences, Inc. | 15 | $209 |
| Otsuka America Pharmaceutical, Inc. | 8 | $184 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 6 | $143 |
| Gilead | 3 | $136 |
| Indivior Inc. | 5 | $89 |
| Lundbeck LLC | 4 | $64 |
| Exact Sciences | 2 | $40 |
| Corium, LLC | 2 | $38 |
| Noven Therapeutics, LLC | 2 | $28 |
| E.r. Squibb & Sons, L.L.C. | 2 | $27 |
| Supernus Pharmaceuticals, Inc. | 1 | $24 |
| Luye Pharma (USA) Ltd. | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| GSK | 1 | $16 |
| OWP Pharmaceuticals, Inc. | 1 | $16 |
| Braeburn Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Mavyret$125
How this compares
$1,959 in reported general payments places this provider in the 75th percentile of 4,392 family providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 22 | $21,704 |
| EliquisApixaban | 12 | $6,806 |
| VascepaIcosapent Ethyl | 13 | $4,413 |
| JanumetSitagliptin Phos/Metformin Hcl | 13 | $3,616 |
| PremarinEstrogens, Conjugated | 12 | $2,523 |
| Colesevelam Hcl | 14 | $1,546 |
| Atorvastatin Calcium | 179 | $1,226 |
| Omeprazole | 61 | $844 |
| Oxybutynin Chloride ErOxybutynin Chloride | 25 | $627 |
| Metoprolol Succinate | 57 | $583 |
| Metformin Hcl | 86 | $526 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 22 | $510 |
| Gabapentin | 41 | $468 |
| Famotidine | 59 | $467 |
| Levothyroxine Sodium | 74 | $446 |
Paid to pharmacies, not to this prescriber.
Other family in Indianapolis
- Tina SizemoreIndianapolis$888K
- Marla MosesIndianapolis$142K
- Leslye FisherIndianapolis$73K
- Alicia WettrickIndianapolis$72K
- Christine BaltIndianapolis$30K
- Kathryn KennedyIndianapolis$29K
- Andrea RandallIndianapolis$27K
- Deidre ArmsIndianapolis$26K
- Carrie GravesIndianapolis$16K
- Dominique LevequeIndianapolis$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.